Loading...
•
Mar 31, 2022
MannKind Q1 2022 Earnings Report
MannKind reported first quarter 2022 financial results.
Key Takeaways
MannKind Corporation reported total revenues of $12.0 million for the first quarter of 2022, with Afrezza net revenue increasing by 21% compared to the first quarter of 2021. The net loss for the quarter was $26.0 million, or $0.10 per share.
Afrezza Net Revenue of $9.8 million, a 21% increase compared to Q1 2021.
Afrezza Gross Margin was 77%, with Gross Profit increasing by 99% compared to Q1 2021.
Cash, Cash Equivalents, and Investments totaled $233.0 million as of March 31, 2022.
Tyvaso DPI PDUFA date is set for May 2022.
Revenue by Segment
Forward Guidance
The company is focused on supporting United Therapeutics in their planned commercial launch of Tyvaso DPI.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...